Splet13. nov. 2024 · At this analysis the median OS (1130 days) exceeded the median follow-up time (867 days). This phenomenon also occurred for data censored on December 31, 2024, with the median OS (1130 days) also exceeding the median follow-up time (956 days). Splet03. sep. 2024 · Note that if the person had died instead of being lost to follow up, survival would have dropped to 40% and the median survival would indeed have been 4 years. Time = 4.5: We have 4 people in our sample, and only one of them is alive (survival = 0.25)
Comparison of the long-term efficacy and safety of multiple
Splet05. maj 2024 · Median follow-up for people who received two doses was 48 days (IQR 30–60). Table 1 Numbers and proportions of people fully vaccinated with BNT162b2 in the Israel population aged 16 years and older (Jan 24 to April 3, 2024) Data are n or n (%). * Defined as people for whom at least 7 days had passed after the second dose of … Splet08. avg. 2016 · RMST is a time-dependent measure and is typically calculated over a defined period that has adequate follow-up; hence the description restricted mean survival time. Note that because PFS events happen sooner than deaths, the true additivity of the relationship, mean PFS + mean SPP = mean OS, may be obscured. how to use mouse on double monitor
How Median Follow-up Time Informs Survival Outcomes: …
SpletSince you swapped the meaning of survival and censored, this value is really the median followup time. Note that the Kaplan-Meier graph created this way (which tracks number of patients being followed over time) is distinct from the Kaplan-Meier graph that tracks percent survival over time. 1. M Schemper and TL Smith. Splet12. feb. 2024 · The median follow-up for the observation group is 46 months (based on the reverse Kaplan-Meier method 26) and, if the outcome of interest is the percentage of … Splet26. avg. 2024 · At a median follow-up time of 100 months, four deaths were reported. A 59-year-old and heavy smoker patient died due to lung cancer 8 years after LN diagnosis, during which he was on immunosuppressive treatment (he received CYC as induction treatment followed by MPA for 3 years and AZA, due mainly to extrarenal manifestations, … organizational markets vs consumer markets